Investment Summary

Easton Capital Investment Group Invests In electroCore

On April 9, 2013, venture capital firm Easton Capital Investment Group invested in medical products company electroCore

Investment Highlights
  • This is Easton Capital Investment Group’s 5th transaction in the Medical Products sector.
  • This is Easton Capital Investment Group’s 24th transaction in the United States.
  • This is Easton Capital Investment Group’s 2nd transaction in New Jersey.

Investment Summary
Date 2013-04-09
Target electroCore
Sector Medical Products
Investor(s) Easton Capital Investment Group
Deal Type Venture

Target

electroCore

Rockaway, New Jersey, United States
electroCore is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. electroCore was founded in 2005 and is based in Rockaway, New Jersey.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Easton Capital Investment Group

New York, New York, United States

Investor Investor Investor Investor Investor

Category Venture Capital Firm
Founded 2000
PE ASSETS 200M USD
Size Small
Type Sector Focused
DESCRIPTION

Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York.

DEAL STATS #
Overall 24 of 25
Sector (Medical Products) 5 of 6
Type (Venture) 21 of 22
State (New Jersey) 2 of 2
Country (United States) 24 of 25
Year (2013) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-02-21 Medikly

New York, New York, United States

Medikly is pharma’s first and only unified, cloud-based platform that helps brands better reach, engage, and understand physicians across multiple touchpoints. Medikly’s platform goes beyond current technology solutions by delivering deeper content, interactive experiences, and a robust set of measurable and actionable big data analytics. Medikly was launched in 2011 and is based in New York City.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-19 bluebird bio

Somerville, Massachusetts, United States

bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. bluebird bio was founded in 1992 and is based in Somerville, Massachusetts.

Sell -
Mergr

Product

Company

Legal